Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of tamsulosin for the treatment of benign prostatic hyperplasia: a meta analysis
    Ren Rui-min
    Kou Min
    Lan Xiao-xu
    CHINESE MEDICAL JOURNAL, 2010, 123 (02) : 234 - 238
  • [2] EFFICACY AND SAFETY OF THE ALPHA-1 BLOCKER DOXAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - ANALYSIS OF 5 STUDIES
    JANKNEGT, RA
    CHAPPLE, CR
    EUROPEAN UROLOGY, 1993, 24 (03) : 319 - 326
  • [3] Comparison of a phytotherapeutic agent (Permixon) with an α-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia:: A 1-year randomized international study
    Debruyne, F
    Koch, G
    Boyle, P
    Da Silva, FC
    Gillenwater, JG
    Hamdy, FC
    Perrin, P
    Teillac, P
    Vela-Navarrete, R
    Raynaud, JP
    EUROPEAN UROLOGY, 2002, 41 (05) : 497 - 506
  • [4] Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia
    Simaioforidis, Vasileios
    Papatsoris, Athanasios G.
    Chrisofos, Michael
    Chrisafis, Manolis
    Koritsiadis, Sotirios
    Deliveliotis, Charalambos
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (03) : 243 - 248
  • [5] Risk stratification for benign prostatic hyperplasia (BPH) treatment
    Emberton, Mark
    Fitzpatrick, John M.
    Rees, Jon
    BJU INTERNATIONAL, 2011, 107 (06) : 876 - 880
  • [6] Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
    Zhou, Zhongbao
    Cui, Yuanshan
    Wu, Jitao
    Ding, Rui
    Cai, Tong
    Gao, Zhenli
    BMC UROLOGY, 2019, 19 (1)
  • [7] A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha(1A)-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia)
    Abrams, P
    Speakman, M
    Stott, M
    Arkell, D
    Pocock, R
    BRITISH JOURNAL OF UROLOGY, 1997, 80 (04): : 587 - 596
  • [8] The treatment of benign prostatic hyperplasia with alpha 1-adrenoceptor antagonists
    Heimbach, D
    Muller, SC
    UROLOGE A, 1997, 36 (01): : 18 - 34
  • [9] Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting
    Flannery, Michael T.
    Ramsdell, Joe
    Ranhosky, Alan
    Davidai, Giora
    Ruoff, Gary
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (04) : 721 - 730
  • [10] Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial
    Gotoh, M
    Kamihira, O
    Kinukawa, T
    Ono, Y
    Ohshima, S
    Origasa, H
    BJU INTERNATIONAL, 2005, 96 (04) : 581 - 586
12345